Author: Reporter

Shifting political landscape: Why voters may face a Trump-Biden rematch in the 2024 election

The end of Labor Day weekend would typically mark the start of a furious sprint to the Iowa caucuses as candidates battle for their party’s presidential nomination. But as the 2024 campaign comes into greater focus, the usual frenzy is yielding to a sense of inevitability. Among Republicans, Donald Trump is dominating the primary field, outpacing rivals with resumes as governors, diplomats, and entrepreneurs that would normally prove compelling. The former president’s strength comes despite — or perhaps because of — multiple criminal indictments that threaten to overshadow any serious debate about the future of the country. And for...

Read More

Insurrection Act: Legacy law could allow a re-elected Trump to weaponize U.S. military against his enemies

Campaigning in Iowa this year, Donald Trump said he was prevented during his presidency from using the military to quell violence in primarily Democratic cities and states. Calling New York City and Chicago “crime dens,” the criminally indicted front-runner for the 2024 Republican presidential nomination told his audience, “The next time, I’m not waiting. One of the things I did was let them run it and we’re going to show how bad a job they do,” he said. “Well, we did that. We don’t have to wait any longer.” Trump has not spelled out precisely how he might use...

Read More

Zepbound: FDA approves new version of Eli Lilly’s Mounjaro diabetes drug to assist with weight loss

A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced in early November. The U.S. Food and Drug Administration approved Eli Lilly’s drug, named Zepbound. The drug, also known as tirzepatide, helped dieters lose as much as 40 to 60 pounds in testing. Zepbound is the latest diabetes drug approved for chronic weight management, joining Novo Nordisk’s Wegovy, a high-dose version of its diabetes treatment Ozempic. Both are weekly injections. The FDA approved Lilly’s drug for people who are considered obese, with a body mass index of 30 or higher,...

Read More

Despite little research the mind-altering drug ketamine has become a new treatment for pain

As U.S. doctors scale back their use of opioid painkillers, a new option for hard-to-treat pain is taking root: ketamine, the decades-old surgical drug that is now a trendy psychedelic therapy. Prescriptions for ketamine have soared in recent years, driven by for-profit clinics and telehealth services offering the medication as a treatment for pain, depression, anxiety and other conditions. The generic drug can be purchased cheaply and prescribed by most physicians and some nurses, regardless of their training. With limited research on its effectiveness against pain, some experts worry the U.S. may be repeating mistakes that gave rise to...

Read More

Rise of mysterious respiratory infections in Chinese children triggers U.N. health investigation

The World Health Organization says it has made an official request to China for information about a potentially worrying spike in respiratory illnesses and clusters of pneumonia in children. The U.N. health agency cited unspecified media reports and a global infectious disease monitoring service as reporting clusters of undiagnosed pneumonia in children in northern China. In a statement on November 22, WHO said it was unclear whether those were linked to a rise in respiratory infections reported by Chinese authorities. Outside scientists said the situation warranted close monitoring, but were not convinced that the recent spike in respiratory illnesses...

Read More

Elevating free speech: Universities form partnership in response to threats against democracy

The presidents of a wide-ranging group of 13 universities are elevating free speech on their campuses this academic year, as part of a new nonprofit initiative announced in August to combat what organizers call dire threats to U.S. democracy. The Campus Call for Free Expression will take different forms on different campuses. The campaign, created by The Institute for Citizens & Scholars with funding from the Knight Foundation is designed to cultivate the freedom of expression on campuses and help students work together to find solutions to complicated, divisive problems. “The national context of the deep political polarization, the...

Read More